A pilot study evaluating microbiome profiles of breast tissue, vaginal samples and stool in patients with benign breast lesions (fibroadenoma)
This pilot study reveals that while fibroadenoma tissue lacks cultivable bacteria, it harbors a distinct 16S rRNA-detected microbiome that shares specific taxa with the gut and vaginal tracts, showing greater similarity to the gastrointestinal microbiota than to the reproductive tract.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
For decades, the human breast was thought to be a sterile sanctuary, a place inside the body where bacteria could not survive. This view held firm until recent years, when scientists began to realize that healthy breast tissue, like the gut and the skin, hosts its own community of microscopic life. These tiny residents, known as the microbiome, are not just passive passengers; they interact with human cells and may influence health and disease. While researchers have spent considerable time studying the bacteria found in breast cancer, far less is known about the microbial world inside benign lumps, such as fibroadenomas. These non-cancerous growths are common, affecting more than half of all women at some point, yet their internal environment remains a mystery. A critical question has emerged: do these breast lumps contain their own unique bacteria, or do they simply reflect the microbial communities found elsewhere in the body, such as the digestive tract or the reproductive system?
A team of researchers at the Jagiellonian University Medical College in Poland set out to explore this question through a small, focused investigation. They recruited three women, all in their twenties or thirties, who had been diagnosed with fibroadenomas. To get a complete picture, the scientists collected samples from three different parts of each woman's body: the breast tumor itself, the vagina, and the stool. By taking samples from these distinct locations at the same time, the team could directly compare the bacterial residents of the breast against those of the gut and the reproductive tract. They used a combination of methods to find these microbes. First, they tried to grow the bacteria in a lab dish, a technique that only catches living, active organisms. Then, they used genetic sequencing to read the DNA of all bacteria present, even those that are dead or too small to grow in a dish. Finally, they used a targeted search to look for specific, hard-to-find bacteria that are known to hide in the body.
The results painted a clear picture of three very different worlds. When the researchers tried to grow bacteria from the stool and vaginal samples, they found a bustling city of life. The gut samples were teeming with millions of bacteria per gram, dominated by familiar gut dwellers. The vaginal samples also showed high numbers of bacteria, primarily a type known as Lactobacillus, which is well-known for keeping the reproductive tract healthy. In stark contrast, when they tried to grow bacteria from the fibroadenoma tissue, the dishes remained empty. No living bacteria could be cultivated from the breast tumors. This suggested that if bacteria were present in the breast, they were either dead, dormant, or present in such low numbers that they could not be grown using standard methods.
However, the genetic sequencing told a different, more complex story. Even though no living bacteria could be grown from the breast tissue, the DNA analysis revealed that the tumors were not empty. They contained a diverse mix of bacterial genetic material. The composition of this bacterial community was unique to the breast, distinct from both the gut and the vagina. The breast tissue hosted a mix of bacteria that included some typically found in the gut, some usually associated with the skin, and a few types that were not common in either of those places. For instance, the researchers found a specific type of bacteria called Sporosarcina in the breast tissue of two of the women, a type that was virtually absent from their gut or vaginal samples. Another unique finding was the presence of Bradyrhizobium, a genus rarely reported in breast tissue, which appeared in all three patients.
Despite these differences, the study also found evidence of overlap, suggesting that the breast does not exist in isolation. The researchers detected the same species of bacteria in the breast tissue that were also present in the gut or the vagina of the same woman. For example, in one patient, a specific type of Lactobacillus was found in both the vagina and the breast tumor. In another case, a bacterium called Ureaplasma urealyticum, which is typically associated with the urinary and reproductive tracts, was found in the breast tissue, the vagina, and the stool of the same woman. This suggests that bacteria from other parts of the body might travel to the breast, perhaps through the bloodstream or the lymphatic system, or that the breast simply shares a common pool of bacteria with the rest of the body.
The study also highlighted the importance of using multiple methods to study these tiny communities. The genetic sequencing found a much wider variety of bacteria than the culture method, including many that are difficult to grow in a lab. Conversely, the culture method successfully identified some specific bacteria that the genetic search missed. By combining these approaches, the researchers could build a more complete map of the microbial landscape. They also used a specialized test to look for atypical bacteria that are known to cause chronic inflammation. This test confirmed the presence of Ureaplasma and another bacterium called Mycoplasma in the samples, further supporting the idea that these hard-to-detect microbes are part of the breast environment.
While the study was small, involving only three women, it provides a crucial first step in understanding the microbial life of benign breast tumors. The findings suggest that fibroadenomas are not sterile, but they do harbor a unique community of bacteria that differs from the gut and the vagina. At the same time, the presence of shared bacterial species hints at a connection between these distant parts of the body. The researchers emphasize that because the study was so small, these results are preliminary and should be seen as a starting point for larger investigations. They do not prove that these bacteria cause the tumors, nor do they explain exactly how the bacteria get there. However, the work confirms that the breast is part of a larger, interconnected microbial ecosystem, and that understanding the bacteria living within benign lesions may be just as important as understanding those in cancer. As science moves forward, these small, hidden communities may hold key clues to the health and disease of the human breast.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.